Blog

Atalaya Mining (LSE:ATYM) reported first-quarter 2026 copper production of 9,939 tonnes at its Proyecto Riotinto operation, down from 14,291 tonnes a year earlier. The decline was primarily due to unusually heavy rainfall, which restricted access to higher-grade ore zones and led to increased reliance on lower-grade stockpiles, reducing both mined volumes and overall head grades.

Despite the weather-related disruption and potential cost pressures linked to geopolitical factors, the company continues to benefit from stronger realised copper prices. Its financial position has also improved, with net cash reaching €266 million following a recent equity raise. Atalaya is advancing several key growth projects, including San Dionisio, Masa Valverde, and Touro, which are expected to strengthen its exposure to long-term demand driven by electrification and renewable energy trends.

The company is currently reassessing its production and cost guidance for 2026, with an update expected alongside its first-quarter financial results. In parallel, it is continuing stripping and drilling programmes aimed at improving access to higher-grade material at Riotinto and supporting future polymetallic processing capabilities.

Progress is also being made on permitting and exploration. At the Touro project, the removal of a previous negative environmental ruling marks a positive step forward, while ongoing work across Spain and Sweden supports Atalaya’s strategy to expand its resource base and enhance future production potential.

From an investment perspective, the company is supported by strong trailing profitability and a conservative balance sheet with low leverage, offering resilience in a cyclical sector. However, technical indicators remain weak, with the share price trading well below key moving averages, and valuation metrics appear only moderately attractive, with a price-to-earnings ratio of around 23 and a relatively low dividend yield.

More about Atalaya Mining

Atalaya Mining Copper, S.A. is a London-listed copper producer focused on its flagship Proyecto Riotinto in Spain’s Iberian Pyrite Belt. The company produces copper concentrate with silver as a by-product and is pursuing expansion across the Riotinto district, alongside additional projects such as Touro in Galicia and exploration activities in Sweden. Its strategy centres on growing production capacity and diversifying its asset base to capitalise on rising demand for copper in energy transition technologies.

Tharisa (LSE:THS) reported a mixed set of operating results for the second quarter of FY2026, with platinum group metals (PGMs) production declining 11.6% to 34.3 koz due to lower ore grades. In contrast, chrome concentrate output rose 15.6% to 404 kt, supported by improved feed grades and consistent recovery rates.

Favourable commodity pricing helped offset the softer PGM volumes, with the average PGM basket price increasing by nearly 38% and chrome prices also strengthening. This supported an increase in the group’s cash balance to US$184.3 million, even as debt levels rose in line with ongoing underground development and higher working capital requirements.

A key milestone during the quarter was the first blast at the Apollo portal, marking the start of underground mining at the Tharisa Mine. This development is central to the company’s long-term strategy, which includes more than US$500 million of planned investment into underground expansion over the next decade.

Beyond South Africa, Tharisa continued to progress its Karo Platinum project in Zimbabwe, advancing early-stage works and funding arrangements. The company also maintained solid safety performance and reaffirmed its full-year FY2026 guidance of 145,000–165,000 ounces of PGMs and 1.50–1.65 million tonnes of chrome production.

More about Tharisa

Tharisa plc is a mining and metals group incorporated in Cyprus and listed in both Johannesburg and London. The company focuses on the production of platinum group metals and chrome concentrates, with its flagship Tharisa Mine transitioning from open-pit to a combined open-pit and underground operation. It is also developing the Karo Platinum project in Zimbabwe, aiming to build a long-life, large-scale resource base across both PGMs and chrome.

PetroTal (LSE:TAL) reported average group production of 14,907 barrels of oil per day for the first quarter of 2026, representing a 2% decline from the previous quarter but coming in slightly ahead of internal forecasts. Output was primarily driven by the Bretana field, with additional contribution from the Los Angeles field.

Operations at Bretana continue to face constraints, particularly due to limited water reinjection capacity and scheduled tubing replacement work. The company expects drilling activity to resume by October, contingent on finalising a contract for a third-party rig.

Financially, PetroTal ended the quarter with total cash of $128.1 million, including $104.2 million in unrestricted cash. While this reflects a decrease compared to the end of 2025, it remains higher than the same period last year, supported by strong oil prices in March, which approached $90 per barrel. The company also has hedging arrangements in place covering approximately 0.9 million barrels of production through 2026. These hedges currently carry a negative fair value, reflecting the impact of higher spot prices and creating a short-term mark-to-market headwind, even as they provide protection against future price volatility.

More about PetroTal Corp

PetroTal Corp. is an oil and gas development and production company with headquarters in Calgary and Houston, focused on onshore crude oil operations in Peru. Its key asset is the wholly owned Bretana Norte field in Block 95, complemented by production from the Los Angeles field in Block 131. The company has grown to become Peru’s largest crude oil producer and is focused on delivering efficient, safe operations while maintaining strong engagement with local communities.

Sosandar (LSE:SOS) delivered a solid performance for FY26, with revenue increasing 14% to £42.3 million. Growth was driven by a 24% rise in sales through its own website, supported by higher customer traffic, improved conversion rates, and increased purchasing activity from both new and returning shoppers. The brand also maintained strong momentum with third-party partners, ranking among top sellers with retailers such as NEXT, while trading with Marks & Spencer stabilised following disruption from an earlier cyber incident.

The company’s profitability improved significantly, reporting a profit before tax of £0.4 million compared with a loss in the prior year. Gross margins expanded to 63.9%, and net cash rose to £8.4 million, even after share buybacks, highlighting the strength of its cash generation. While its physical stores showed improved performance in their second year—particularly in smaller market towns—they continue to weigh on overall profitability. As a result, Sosandar has decided to pause further store openings and instead focus on improving returns from its existing locations and driving sustainable growth.

From an outlook perspective, the company benefits from positive share price momentum and supportive corporate developments, including strategic execution and insider confidence. However, challenges remain around maintaining consistent profitability and strengthening cash flow, while valuation metrics are less compelling.

More about Sosandar PLC

Sosandar PLC is a UK-based womenswear retailer offering fashion-led, affordable clothing aimed at style-conscious women seeking higher quality than typical value brands. The company primarily sells its own-label products through its website, standalone stores, and partnerships with major retailers such as NEXT and Marks & Spencer.

Founded in 2016 and listed on AIM in 2017, Sosandar focuses on a segment of the market looking for trend-driven, feminine designs. Its strategy combines data-led product development, targeted marketing, and a multi-channel distribution approach to reach customers across both direct and partner platforms.

AB Dynamics (LSE:ABDP) reported a challenging first half, with revenue falling 16% to £48.8 million and the business moving to a statutory operating loss. The decline was largely attributed to delayed customer orders, softer-than-expected activity at its VadoTech testing services unit in China, and a £16.8 million exceptional charge, primarily linked to a non-cash impairment.

Despite the weaker top-line performance, the company preserved its adjusted operating margin at 18.6% and continued to generate strong cash flow, ending the period with net cash of £39.3 million. It also increased its interim dividend by 10% and reaffirmed expectations that full-year adjusted operating profit will meet market forecasts. This confidence is supported by improving order intake, a £47 million order book, and long-term demand trends tied to active safety systems and autonomous vehicle technologies.

Management has initiated a strategic review of the underperforming VadoTech China business, while placing greater emphasis on innovation and product alignment with evolving regulatory requirements and consumer testing standards. The company is also expanding its simulation capabilities, with early interest building around its Delta S3 Spin simulator.

AB Dynamics continues to highlight its diversified customer base, independence from specific OEMs and powertrain technologies, and strong pricing power as key strengths in navigating broader industry and geopolitical challenges. It remains focused on achieving medium-term targets of around 10% annual organic growth, operating margins above 20%, and sustained cash generation to support reinvestment.

From an investment perspective, the group’s solid financial fundamentals and positive management outlook provide support. However, weaker technical indicators point to a more cautious near-term trend, while valuation remains only moderately compelling, balancing the overall outlook.

More about AB Dynamics

AB Dynamics is a UK-based provider of advanced testing, simulation, and measurement solutions for the global transport sector. Its products and services are used by major automotive manufacturers, Tier 1 suppliers, and testing organisations to develop and validate vehicle dynamics, active safety systems, and autonomous driving technologies, including ADAS features.

Oxford Instruments (LSE:OXIG) expects to deliver full-year results in line with market expectations for the period ending 31 March 2026, driven by a stronger second-half performance. Group order intake rose 8% on an organic, constant-currency basis, resulting in a book-to-bill ratio of approximately 1.07. Revenue and margins also improved in the latter half, helped by earlier cost-saving measures within its Belfast imaging operations and continued share buyback activity, reinforcing confidence in the company’s growth trajectory.

The Advanced Technologies division was the key contributor, achieving roughly 30% organic growth in orders. This was fuelled by sustained demand for compound semiconductors and increasing engagement with high-volume manufacturing clients across the U.S. and Europe. A newly secured multi-year contract in April 2026 has further strengthened visibility, with the division’s order book now largely covering expected revenue for FY27 and extending into FY28.

Despite a more challenging macroeconomic backdrop and earlier tariff-related disruptions affecting the Imaging & Analysis segment, the company remains well positioned, supported by strong demand trends and improved operational efficiency.

From an investment standpoint, Oxford Instruments benefits from solid financial performance and proactive capital allocation, including share buybacks. However, relatively high valuation multiples and signs of overbought technical conditions suggest some caution may be warranted. While strategic initiatives and earnings momentum remain positives, attention to liquidity and profitability dynamics will be important going forward.

More about Oxford Instruments

Oxford Instruments is a FTSE 250-listed provider of advanced scientific technology, offering tools, software, and services to both academic and commercial customers globally. Its core focus areas include materials analysis, semiconductor technologies, and healthcare and life sciences, positioning the group to capitalise on growing investment in advanced materials, productivity enhancements, and decarbonisation efforts.

hVIVO (LSE:HVO) has entered into a clinical trial agreement with Traws Pharma to conduct a Phase 2a human challenge study evaluating tivoxavir marboxil, an oral, single-dose antiviral candidate designed to treat both seasonal and avian influenza.

The randomised, double-blind, placebo-controlled trial will be carried out at hVIVO’s quarantine facilities in Canary Wharf and is expected to enrol around 150 healthy participants through its FluCamp volunteer recruitment platform. The study will also utilise the company’s in-house virology laboratories, with the majority of associated revenue anticipated to be recognised during 2026.

This agreement highlights hVIVO’s strategy of leveraging its refined influenza human challenge model and integrated clinical capabilities to deliver faster and more controlled efficacy data compared with conventional field trials. The approach strengthens its role as a comprehensive clinical development partner. For Traws Pharma, the collaboration is intended to generate high-quality clinical data on the safety and effectiveness of its antiviral candidate, supporting further development in a significant global respiratory disease market.

From an investment perspective, the company’s outlook is supported by solid financial performance and an appealing valuation profile. Strong revenue growth and low leverage provide a favourable foundation within the biotechnology sector. While technical indicators point to positive momentum, the shares remain below key moving averages, which may indicate near-term resistance. A relatively low P/E ratio and a reasonable dividend yield further enhance its appeal to value and income-focused investors.

More about hVIVO plc

hVIVO plc is a specialised, full-service clinical development company and a global leader in human challenge trials. It works with seven of the world’s ten largest biopharmaceutical companies, offering an end-to-end platform that spans preclinical planning through to Phase II studies, alongside advanced laboratory services. The business operates across four core areas: consulting, clinical trials, human challenge studies, and laboratory services, with facilities in the UK and Germany.

Porvair (LSE:PRV) said trading in the first four months of 2026 remained in line with expectations, with revenue rising 5% on a constant currency basis. Performance was supported by the group’s diversified operations and stable demand across several core markets. Aerospace continued to show strong order momentum, while nuclear-related activity remained healthy. In contrast, European petrochemical markets and certain automotive segments were softer, and progress in life sciences and environmental laboratories was driven by scheduled product launches.

Within the Metal Melt Quality division, demand for aluminium and superalloy applications stayed resilient. The company’s £5.5 million aluminium cast house facility in Hendersonville, U.S., is progressing toward commissioning in the first half of the year. Meanwhile, the recently acquired Drache business is integrating smoothly and performing in line with expectations.

Despite ongoing geopolitical uncertainties and cost pressures, the board has maintained its full-year outlook. Management pointed to the strength of Porvair’s decentralised manufacturing model, which emphasises localised production, as well as a healthy pipeline of acquisition opportunities under review. The company also plans to host a capital markets event and provide a further update alongside its interim results later in the year.

From an investment standpoint, Porvair’s outlook is supported by solid profitability and a relatively low level of debt. However, this is balanced by more uncertain trends in revenue growth and free cash flow. Share price indicators are mixed, while valuation appears moderate, with a price-to-earnings ratio of around 21.9 and a relatively modest dividend yield.

More about Porvair

Porvair plc is a specialist filtration and environmental technology group focused on designing and manufacturing high-performance consumable filtration products. The company operates across three divisions: aerospace and industrial, laboratory, and metal melt quality. Its products serve a wide range of global markets, including aerospace, nuclear, petrochemical, life sciences, and metals processing, providing exposure to diverse industrial and scientific applications.

Amcomri Group (LSE:AMCO) delivered a record financial performance in 2025, with revenue rising 22% to £70.9 million, adjusted EBITDA increasing 19.3% to £9.2 million, and profit before tax more than doubling to £4.1 million. The results were driven by improved margins and the contribution from earnings-accretive acquisitions. Strong growth across both its Embedded Engineering and B2B Manufacturing divisions, combined with a broad and diversified customer base, helped cushion the impact of weaker conditions in certain markets, while supporting higher earnings per share and asset values despite an increase in net debt.

During the year, the group strengthened its capabilities through acquisitions, including EMC Elite Engineering and the Electronix business of Radnor Technologies—marking its first transaction outside the UK. These additions have supported operational synergies and enhanced management depth across the organisation. After the year-end, Amcomri agreed to acquire Enerveo’s National Compliance and Testing division, further expanding its footprint in electrical testing and compliance services.

Management noted that trading in 2026 has begun in line with expectations, with solid demand across key sectors such as rail electrification, defence, aerospace, power generation, and broader energy markets continuing to support activity.

From an outlook perspective, the company benefits from strong financial momentum and positive share price trends. However, these strengths are balanced by a relatively high valuation, which may indicate limited upside. The lack of recent earnings call insights or major corporate events means these factors do not materially influence the overall investment view.

More about Amcomri Group Plc

Amcomri Group Plc is a UK-focused engineering services and industrial manufacturing business operating under a “Buy, Improve, Build” strategy. Through its Embedded Engineering and B2B Manufacturing segments, the group delivers critical technical services and specialised manufacturing solutions to clients in sectors such as infrastructure, transport, industrials, and energy—often within highly regulated and safety-critical environments.

The company focuses on acquiring small and medium-sized businesses with strong positions in niche B2B markets, particularly in situations involving owner-manager succession. It aims to enhance performance through integration and operational improvements. Built through 19 acquisitions, including multiple bolt-on deals, Amcomri maintains a diversified portfolio that helps provide resilience across different economic cycles.